| scholarly article | Q13442814 |
| P50 | author | Paula J Foster | Q39909428 |
| P2093 | author name string | Gregory A Dekaban | |
| Ronan Foley | |||
| Christiane Mallet | |||
| Christy Willert | |||
| Sonali de Chickera | |||
| P2860 | cites work | CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2 | Q24298801 |
| Human CD4+CD25+ regulatory T cells: proteome analysis identifies galectin-10 as a novel marker essential for their anergy and suppressive function | Q24305624 | ||
| Evaluation of in vivo labelled dendritic cell migration in cancer patients | Q24799742 | ||
| Immunobiology of dendritic cells | Q29547465 | ||
| CXCL12-CXCR4 engagement is required for migration of cutaneous dendritic cells | Q30480094 | ||
| In vivo analysis of dendritic cell development and homeostasis | Q30492687 | ||
| Demonstration of anti-tumor activity of oncolytic measles virus strains in a malignant pleural effusion breast cancer model | Q30496489 | ||
| Jak3 is involved in dendritic cell maturation and CCR7-dependent migration. | Q30873748 | ||
| In vivo MRI cell tracking: clinical studies | Q33803809 | ||
| The chemokine receptor switch paradigm and dendritic cell migration: its significance in tumor tissues | Q33930003 | ||
| Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells | Q34141893 | ||
| Dendritic cells for specific cancer immunotherapy | Q34280913 | ||
| Dendritic cells: sentinels of immunity and tolerance | Q34409370 | ||
| Iron oxide MR contrast agents for molecular and cellular imaging | Q35939108 | ||
| Monitoring cell therapy using iron oxide MR contrast agents | Q35972375 | ||
| Migration of dendritic cell based cancer vaccines: in vivo veritas? | Q36070704 | ||
| B7 costimulation molecules expressed from the herpes simplex virus 2 genome rescue immune induction in B7-deficient mice | Q36315467 | ||
| Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential toll-like receptor ligation | Q36370469 | ||
| Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming | Q36371607 | ||
| Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma | Q36375683 | ||
| Lymph-migrating, tissue-derived dendritic cells are minor constituents within steady-state lymph nodes | Q36979954 | ||
| Double-stranded RNA analog poly(I:C) inhibits human immunodeficiency virus amplification in dendritic cells via type I interferon-mediated activation of APOBEC3G. | Q37033387 | ||
| Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells | Q37139993 | ||
| Mechanisms and consequences of dendritic cell migration | Q37272221 | ||
| Therapeutic dendritic cell vaccination of patients with metastatic renal cell carcinoma: a clinical phase 1/2 trial | Q39941863 | ||
| Chemotaxis of mouse bone marrow neutrophils and dendritic cells is controlled by adp-ribose, the major product generated by the CD38 enzyme reaction. | Q40048284 | ||
| CD38 orchestrates migration, survival, and Th1 immune response of human mature dendritic cells | Q40350282 | ||
| Detection threshold of single SPIO-labeled cells with FIESTA. | Q40464291 | ||
| Differentiation of human dendritic cells from monocytes in vitro using granulocyte-macrophage colony stimulating factor and low concentration of interleukin-4 | Q40618123 | ||
| Optimization of methods to study pulmonary dendritic cell migration reveals distinct capacities of DC subsets to acquire soluble versus particulate antigen | Q41782597 | ||
| Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration. | Q41968893 | ||
| Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients | Q42742001 | ||
| Characterization of an immediate splenic precursor of CD8+ dendritic cells capable of inducing antiviral T cell responses | Q43619496 | ||
| Measles virus induces oncolysis of mesothelioma cells and allows dendritic cells to cross-prime tumor-specific CD8 response | Q45394388 | ||
| HER-2/neu-gene engineered dendritic cell vaccine stimulates stronger HER-2/neu-specific immune responses compared to DNA vaccination | Q45858638 | ||
| Deficient T(H)-1 responses from TNF-alpha-matured and alpha-CD40-matured dendritic cells. | Q46594783 | ||
| Acellular matrix of bovine pericardium bound with L-arginine | Q46610727 | ||
| Immunologic and clinical responses after vaccinations with peptide-pulsed dendritic cells in metastatic renal cancer patients | Q48030305 | ||
| Dendritic cells pulsed with glioma lysates induce immunity against syngeneic intracranial gliomas and increase survival of tumor-bearing mice | Q48483384 | ||
| In vivo leukocyte labeling with intravenous ferumoxides/protamine sulfate complex and in vitro characterization for cellular magnetic resonance imaging | Q48901575 | ||
| Sensitivity of magnetic resonance imaging of dendritic cells for in vivo tracking of cellular cancer vaccines. | Q48922480 | ||
| In vivo magnetic resonance imaging of dendritic cell migration into the draining lymph nodes of mice. | Q50744987 | ||
| The role of ICOS in directing T cell responses: ICOS-dependent induction of T cell anergy by tolerogenic dendritic cells. | Q51782147 | ||
| Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells. | Q55066427 | ||
| Limited Amounts of Dendritic Cells Migrate into the T-Cell Area of Lymph Nodes but Have High Immune Activating Potential in Melanoma Patients | Q58619964 | ||
| P433 | issue | 1 | |
| P921 | main subject | immunology | Q101929 |
| dendritic cell | Q506253 | ||
| P304 | page(s) | 29-41 | |
| P577 | publication date | 2011-12-20 | |
| P1433 | published in | International Immunology | Q15710043 |
| P1476 | title | Cellular MRI as a suitable, sensitive non-invasive modality for correlating in vivo migratory efficiencies of different dendritic cell populations with subsequent immunological outcomes | |
| P478 | volume | 24 |
| Q38174553 | Considerations for the clinical use of contrast agents for cellular MRI in regenerative medicine. |
| Q36563884 | Delivery System of CpG Oligodeoxynucleotides through Eliciting an Effective T cell Immune Response against Melanoma in Mice |
| Q58120574 | Engineering molecular imaging strategies for regenerative medicine |
| Q39253138 | Extensive expansion of primary human gamma delta T cells generates cytotoxic effector memory cells that can be labeled with Feraheme for cellular MRI. |
| Q60704299 | Forming Magnetosome-Like Nanoparticles in Mammalian Cells for Molecular MRI |
| Q46195000 | Image-guided dendritic cell-based vaccine immunotherapy in murine carcinoma models |
| Q39128686 | Imaging tumor growth non-invasively using expression of MagA or modified ferritin subunits to augment intracellular contrast for repetitive MRI. |
| Q34095015 | In vivo tracking of neuronal-like cells by magnetic resonance in rabbit models of spinal cord injury |
| Q38330408 | Nanomaterial applications in multiple sclerosis inflamed brain |
| Q34995056 | Paradoxical decrease in the capture and lymph node delivery of cancer vaccine antigen induced by a TLR4 agonist as visualized by dual-mode imaging |
| Q38103222 | Tracking and evaluation of dendritic cell migration by cellular magnetic resonance imaging |
| Q47296148 | Using MRI cell tracking to monitor immune cell recruitment in response to a peptide-based cancer vaccine |
Search more.